Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher deFilippi

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Clinical Chemistry|November 17, 2011
A novel technology for measuring cumulative cardiac biomarker exposure over time: what happened when we weren't looking?Christopher deFilippi
Circulation|January 31, 2018
The Cardiac Troponin Renal Disease Diagnostic Conundrum: Past, Present, and FutureChristopher deFilippi, Stephen Seliger
Current Cardiology Reports|September 20, 2020
BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor EraMarco Sbolli, Christopher deFilippi
Circulation|October 9, 2023
Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral VisionChristopher deFilippi, Ana Barac
The New England Journal of Medicine|October 24, 2019
PARAGON-HF - Why We Do Randomized, Controlled Clinical TrialsChristopher M O'Connor, Christopher deFilippi
SN Comprehensive Clinical Medicine|December 19, 2022
Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4Andrei Minciunescu, Leonard Genovese, Christopher deFilippi
American Heart Journal|June 18, 2026
Brief Communication: Biomarkers as endpoints in cardiovascular clinical trials -Report from the Cardiovascular Sciences Research ConsortiumKatarina Zeder, Jonathan Seltzer, Christopher DeFilippi
Current Heart Failure Reports|October 5, 2022
Biomarkers in HFpEF for Diagnosis, Prognosis, and Biological PhenotypingMoemen Eltelbany, Palak Shah, Christopher deFilippi
Circulation|February 15, 2021
Efficacy of Neprilysin Inhibition in Women With HFpEF: Beyond Phenotypes and Natriuretic PeptidesLauren B Cooper, Annunziata Cotugno, Christopher deFilippi
BMJ Case Reports|December 15, 2020
Fast and furious: flecainide toxicity presenting as monomorphic ventricular tachycardiaNisha Donthi, Tejasri Chandrabhatla, Leonard Genovese, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Clinical Chemistry|November 17, 2011
A novel technology for measuring cumulative cardiac biomarker exposure over time: what happened when we weren't looking?Christopher deFilippi
Circulation|January 31, 2018
The Cardiac Troponin Renal Disease Diagnostic Conundrum: Past, Present, and FutureChristopher deFilippi, Stephen Seliger
Current Cardiology Reports|September 20, 2020
BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor EraMarco Sbolli, Christopher deFilippi
Circulation|October 9, 2023
Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral VisionChristopher deFilippi, Ana Barac
The New England Journal of Medicine|October 24, 2019
PARAGON-HF - Why We Do Randomized, Controlled Clinical TrialsChristopher M O'Connor, Christopher deFilippi
SN Comprehensive Clinical Medicine|December 19, 2022
Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4Andrei Minciunescu, Leonard Genovese, Christopher deFilippi
American Heart Journal|June 18, 2026
Brief Communication: Biomarkers as endpoints in cardiovascular clinical trials -Report from the Cardiovascular Sciences Research ConsortiumKatarina Zeder, Jonathan Seltzer, Christopher DeFilippi
Current Heart Failure Reports|October 5, 2022
Biomarkers in HFpEF for Diagnosis, Prognosis, and Biological PhenotypingMoemen Eltelbany, Palak Shah, Christopher deFilippi
Circulation|February 15, 2021
Efficacy of Neprilysin Inhibition in Women With HFpEF: Beyond Phenotypes and Natriuretic PeptidesLauren B Cooper, Annunziata Cotugno, Christopher deFilippi
BMJ Case Reports|December 15, 2020
Fast and furious: flecainide toxicity presenting as monomorphic ventricular tachycardiaNisha Donthi, Tejasri Chandrabhatla, Leonard Genovese, et al.
Pageof 14